Vitamin B12 concentration, memory performance, and hippocampal structure in patients with mild cognitive impairment

verfasst von
Theresa Köbe, A Veronica Witte, Ariane Schnelle, Ulrike Grittner, Valentina A Tesky, Johannes Pantel, Jan Philipp Schuchardt, Andreas Hahn, Jens Bohlken, Dan Rujescu, Agnes Flöel
Abstract

BACKGROUND: Low-normal concentrations of vitamin B-12 (VitB12) may be associated with worse cognition. However, previous evidence has been mixed, and the underlying mechanisms remain unclear.

OBJECTIVE: We determined whether serum VitB12 concentrations within the normal range were linked to memory functions and related neuronal structures in patients with mild cognitive impairment (MCI).

DESIGN: In a cross-sectional design, we assessed 100 amnestic MCI patients (52 women; age range: 50-80 y) with low- and high-normal VitB12 concentration (median split: 304 pmol/L) for memory functions with the use of the Auditory Verbal Learning Test. MRI was performed at 3 tesla (n= 86) for the estimation of the volume and microstructure of the hippocampus and its subfields as indicated by the mean diffusivity on diffusion-weighted images. With the use of a mediation analysis, we examined whether the relation between VitB12 and memory performance was partially explained by volume or microstructure.

RESULTS: MCI patients with low-normal VitB12 showed a significantly poorer learning ability (P= 0.014) and recognition performance (P= 0.008) than did patients with high-normal VitB12. Also, the microstructure integrity of the hippocampus was lower in patients with low-normal VitB12, mainly in the cornu ammonis 4 and dentate gyrus region (P= 0.029), which partially mediated the effect of VitB12 on memory performance (32-48%). Adjustments for age, sex, education, apolipoprotein E e4 status, and total homocysteine, folate, and creatinine did not attenuate the effects.

CONCLUSIONS: Low VitB12 concentrations within the normal range are associated with poorer memory performance, which is an effect that is partially mediated by the reduced microstructural integrity of the hippocampus. Future interventional trials are needed to assess whether supplementation of VitB12 may improve cognition in MCI patients even in the absence of clinically manifested VitB12 deficiency. This trial was registered at clinicaltrials.gov as NCT01219244.

Organisationseinheit(en)
Institut für Lebensmittelwissenschaft und Humanernährung
Abteilung Ernährungsphysiologie und Humanernährung
Externe Organisation(en)
Charité - Universitätsmedizin Berlin
Universitätsklinikum Leipzig
Goethe-Universität Frankfurt am Main
Arztpraxis für Neurologie, Psychiatrie und Psychotherapie Berlin
Martin-Luther-Universität Halle-Wittenberg
Typ
Artikel
Journal
American Journal of Clinical Nutrition
Band
103
Seiten
1045-1054
Anzahl der Seiten
10
ISSN
0002-9165
Publikationsdatum
04.2016
Publikationsstatus
Veröffentlicht
Peer-reviewed
Ja
ASJC Scopus Sachgebiete
Ernährung und Diätetik, Medizin (sonstige)
Elektronische Version(en)
https://doi.org/10.3945/ajcn.115.116970 (Zugang: Offen)